These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22456311)

  • 1. Soluble platelet/endothelial cell adhesion molecule (sPECAM)-1 is increased in polycystic ovary syndrome and related to endothelial dysfunction.
    Pepene CE
    Gynecol Endocrinol; 2012 May; 28(5):370-4. PubMed ID: 22456311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin improves endothelial function and carotid intima media thickness in patients with PCOS.
    Kaya MG; Yildirim S; Calapkorur B; Akpek M; Unluhizarci K; Kelestimur F
    Gynecol Endocrinol; 2015 May; 31(5):401-5. PubMed ID: 25791462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.
    Pepene CE
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):119-25. PubMed ID: 21740456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial.
    Moro F; Morciano A; Tropea A; Sagnella F; Palla C; Scarinci E; Ciardulli A; Martinez D; Familiari A; Liuzzo G; Tritarelli A; Cosentino N; Niccoli G; Crea F; Lanzone A; Apa R
    Reprod Sci; 2013 Dec; 20(12):1508-17. PubMed ID: 23690338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study.
    Naka KK; Kalantaridou SN; Bechlioulis A; Kravariti M; Kazakos N; Katsouras CS; Tsatsoulis A; Michalis LK
    Gynecol Endocrinol; 2011 Sep; 27(9):615-21. PubMed ID: 21329419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
    Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
    Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
    Sorensen MB; Franks S; Robertson C; Pennell DJ; Collins P
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):655-9. PubMed ID: 17054469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
    Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
    Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
    Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome.
    Celik C; Bastu E; Abali R; Alpsoy S; Guzel EC; Aydemir B; Yeh J
    Gynecol Endocrinol; 2013 May; 29(5):488-91. PubMed ID: 23480818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.
    Cakiroglu Y; Vural B; Isgoren S
    Arch Gynecol Obstet; 2013 Jul; 288(1):213-20. PubMed ID: 23377194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
    Pepene CE; Ilie IR; Marian I; Duncea I
    Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
    Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective.
    Romualdi D; Costantini B; Selvaggi L; Giuliani M; Cristello F; Macrì F; Bompiani A; Lanzone A; Guido M
    Hum Reprod; 2008 Sep; 23(9):2127-33. PubMed ID: 18567896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of endothelial function in women with polycystic ovary syndrome.
    Lowenstein L; Damti A; Pillar G; Shott S; Blumenfeld Z
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):208-12. PubMed ID: 17374431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin administration improves endothelial function in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Protogerou A; Piperi C; Papamichael C; Aessopos A; Lekakis J; Mavrikakis M
    Eur J Endocrinol; 2005 May; 152(5):749-56. PubMed ID: 15879361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate.
    Gode F; Karagoz C; Posaci C; Saatli B; Uysal D; Secil M; Akdeniz B
    Arch Gynecol Obstet; 2011 Oct; 284(4):923-9. PubMed ID: 21140159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.